TARIS Bio is developing transformational therapies to treat people with debilitating urological disorders. The company is unlocking novel epithelial biology through continuous disease engagement with its unique platform. TARIS has lead programs in bladder cancer and overactive bladder, which position the company to improve patient health and redefine urologic care.
